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Abstract

Iron regulates mRNA translation initiation through RNA iron responsive element (IRE)

By Jia Ma
Advisor: Professor Dixie J. Goss
The non-coding IRE-RNA structure, a 30 nt stem loop structure, regulates synthesis of proteins
in iron trafficking, cell cycling, and nervous system function. IRE-RNA binding with iron
regulatory protein (IRP) proteins inhibits ribosome accessing mRNA. Increasing iron
concentration decreases IRP binding with IRE-RNA. Previous models of IRE-mRNA translation
regulation concentrate on Fe-S binding to IRP and IRP degradation after release from IRE-RNA.
These models lack information on the details of decreasing IRE-RNA/IRP protein binding with
iron concentration elevation. This research shows 1. Eukaryotic initiation factor 4F (eIF4F) binds
to IRE-RNA with high affinity and works as a positive control element in mRNA translation. 2.
eIF4F, IRP competitively bind to IRE-RNA. 3. Fe2+ increases eIF4F/IRE-RNA binding affinity,
which outcompetes IRP binding. 4. Fe2+ induces an IRE-RNA conformation change leading to
changes in binding affinity with eIF4F and IRP. 5. M7GTP cap doesn’t affect eIF4F or IPR1
binding with 73 nt of the 5’ noncoding region mRNA which includes the IRE 6. eIF4F/IRE-RNA
has a much longer life time than IRP1/IRE-RNA which suggests both kinetics and stability of the
complexes are important. 7. eIF4G, a subunit of eIF4F, binds to IRE-RNA without other subunits.
A novel regulatory mechanism is proposed where metabolic iron (Fe2+) induces IRE-RNA
conformation change to decrease inhibitor protein (IRP) binding and increase activator protein
(eIF4F) binding, indicating IRE-RNA act as a riboregulator.
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Introduction
Iron adsorption
Iron, an essential nutrient for human beings, plays an important role in biochemical activities.
Iron deficiency is the most prevalent nutrition disorder in the world (Zimmermann and Hurrell
2007). However iron overload can damage body tissue (Shander, Berth et al. 2012) and may be
related to increasing risk of human cancer (Stevens, Graubard et al. 1994; Kabat and Rohan
2007). For adults, male body iron is about 3.8 gram and female body iron is about 2.3 gram
(Swanson 2003). In order to replenish iron loss from sweat, urine, sloughed intestinal mucosal
cells, and other blood loss, people need to adsorb 1-2 mg of iron daily from food (Anderson,
Shen et al. 2012; Shander, Berth et al. 2012). Humans adsorb iron through enterocyte in small
intestines by divalent metal transport 1 (DMT1). Only the divalent iron form, ferrous (Fe2+) is
suitable for adsorption. However 90% of dietary iron is in the ferric form (Fe3+) and the other 10%
is in the heme form(Munoz, Garcia-Erce et al. 2011). In the intestinal lumen, ferric (Fe3+) is
reduced to ferrous (Fe2+) by ferric reductases (Kohgo, Ikuta et al. 2008). DMT1 transports the
diavalent ionic iron (Fe2+) across the enterocyte apical membrane (Franken, Lokman et al. 2011;
Wang and Pantopoulos 2011). The heme iron is transported to the enterocyte by unidentified
heme transporters (Munoz, Garcia-Erce et al. 2011; Wang and Pantopoulos 2011).

In the

enterocyte, transported heme will be metabolized into ferrous (Fig 1).
After iron is adsorbed into the enterocyte, ferrous iron is exported across the basolateral
membrane into the plasma by ferroportin. Ferroportin iron export is coupled with oxidizing
ferrous iron back into ferric iron by the transmembrane copper-dependent ferroxidase, hephaestin.
The re-oxidized ferric iron is circulated in the plasma by binding with transferrin (Tf) (Swanson
2003; Wang and Pantopoulos 2011). Transferrin not only maintains iron in a soluble form but
also as the main iron vehicle delivers iron to different cells. In humans, plasma transferrin iron
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saturation indicates iron level: transferrin iron saturation around 30% shows normal iron level:
transferrin iron saturation below 16% shows iron deficiency and transferrin iron saturation
above 45% shows iron overload. If plasma transferrin iron saturation goes over 60%, the
accumulated free non-protein binding iron can damage organs (Hentze, Muckenthaler et al. 2010;
Meyron-Holtz, Moshe-Belizowski et al. 2011; Munoz, Garcia-Erce et al. 2011). Transferrin
bound iron enters the target cells by transferrin receptor 1 (TfR1) mediated endocytosis. The
transferrin receptor 1 (TfR1) has around 500-fold higher affinity for iron loaded transferrin
(holo-Tf) than for iron released transferrin ( apo-Tf) (Wang and Pantopoulos 2011). The TfR1
and Tf affinity changes help apo-Tf dissociation with TfR1 and enable recapture of Fe3+. In the
target cell, released Fe3+ is reduced to Fe2+ by metalloreductase Steap3 (Fig 2) (Ohgami,
Campagna et al. 2005; Richardson, Lane et al. 2010).
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Figure 1 Iron adsorption from intestinal lumen to enterocytes (Wang and Pantopoulos 2011)
Enterocytes absorb inorganic or heme iron from the diet by DMT1 and excrete iron through
ferroportin protein. Iron is reoxidized into ferric form in body plasma and binds to Tf.
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Ferritin Protein
Most cellular ferrous iron is used in mitochondria for enzymatic functions. The excess
intracellular iron is stored in the iron storage protein, ferritin. From microorganism to human,
ferritin is the protein that stores cellular iron in a water soluble, non-toxic way (Crichton and
Declercq 2010). Ferritin is a 12 nm diameter spherical protein with an 8 nm diameter hollow
center (Watt 2011). Mammalian ferritin is a hetero-polymeric protein assembled by 24 subunits
(Fig 3). Those 24 subunits are classified into two subunit types, the H and L subunits (Andrews
2010; Watt 2011). Both types of subunits have similar 5 α helices structure but different amino
acids sequence (Crichton and Declercq 2010). The H subunit has ferroxidase activity, oxidizing
ferrous iron into ferric iron. The L subunit lacks oxidizing activity but it provides the ligand for
ferric binding and initiates iron nucleation (Friedman, Arosio et al. 2011). In mammals, ferritin
can be assembled in different proportions of H and L subunits, which are tissue specific. High
proportion of H subunit ferritin is found in heart, kidney and bone marrow and high proportion
of L subunits ferritin is found in liver and spleen (Friedman, Arosio et al. 2011; Meyron-Holtz,
Moshe-Belizowski et al. 2011) .
Besides iron utilization and storage, 3% to 5% total cellular iron forms an accessible and
transient iron ion pool, which is named as liable iron pool (LIP) (Kruszewski 2003; Kruszewski
and Iwanenko 2003; Wang and Pantopoulos 2011). The LIP consists of both ferrous (Fe2+) and
ferric (Fe3+) ion associated with lower molecular weight chelators, such as citrate, phosphate and
other organic ions (Gebauer and Hentze 2004). The cytosolic LIP hemostasis is directly related
to the ferritin expression.
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Figure 2 Cellular iron uptake (Wang and Pantopoulos 2011)
Cell adsorbs iron through endocytosis by binding with transferrin receptors. Cellular iron is
utilized in mitochondria for enzymatic activities and stored in ferritin to keep iron harmless.
Liable iron pool indicates cellular iron level.
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Figure 3 Ferritin molecular symmetry (Watt 2011)
(a) Diagram illustrating the 24 subunits symmetry in ferritin (b) ferritin molecule viewed from 4fold symmetry axis. (c) ferritin molecule viewed from the 3-fold symmetry axis .
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Ferritin has a dual role in LIP hemostasis. As the main iron storage protein, ferritin binds to iron
to keep iron in a soluble state and away from harmful redox reaction. One ferritin can store up to
4500 iron atoms in its hollow center (Andrews 2010), but ferritin can also release iron into LIP to
stabilize the cellular iron level under low iron conditions (Preiss, Baron-Benhamou et al. 2003).
Eukaryotic mRNA structure
Gene expression starts with transcription of DNA into RNA, and followed by translation of RNA
into protein. As a messenger in gene expression, RNA provides a target in protein synthesis
control. Most eukaryotic mRNA can be divided into 5 parts: capped 5’ end, 5’ noncoding region,
open reading frame (ORF), 3’ noncoding region, and 3’ end poly A tails (Fig 4). Eukaryotic
mRNA has m7GTP at the 5’end, which is a strong positive control element for mRNA translation
and is required for most mRNA translation. The open reading frame encodes the amino acid
sequence. Between the 5’end m7GTP cap and ORF is the 5’ noncoding region around hundred
nucleotides. Several mRNA control elements can be found in the 5’ noncoding region, such as
internal ribosome entry site (IRES), upstream open reading frame (uORFs), and small structure
elements. Those elements have different effects on mRNA translation. IRES can recruit the
ribosome to mRNA independent of the m7GTP Cap. It has been shown there are at least 10% of
cellular mRNA that initiates mRNA translation via IRES (Gebauer and Hentze 2004; Komar and
Hatzoglou 2011). uORFs are small open reading frame which can reduce translation from the
main ORF. The small structure elements in 5’noncoding region binding with protein and RNA
usually have negative effects on mRNA translation. Poly A tail is the 25 to 200 adenine
nucleotides added to the 3’end of mRNA and is a positive control element for mRNA translation.
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Between the ORF and poly A tail is 3’ end noncoding region, which has 200 to 800 nucleotides
responsible for stabilization and subcellular localization of the mRNA .

Figure 4 Eukaryotic mRNA structure (Gebauer and Hentze 2004)
The m7Gppp structure is at the 5’ends of mRNA and poly A structure is at the 3’end of mRNA.
The green rectangle box shows 5’ noncoding region. The red rectangle box shows 3’ noncoding
region. Green oval in the 5’ noncoding region indicates other protein and RNA binding sites in
mRNA.
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IRE/IRP system
As an important protein for cellular iron hemostasis, ferritin protein expression is controlled at
the translational level with the changes of iron concentration. At the end of 20th century,
researchers identified a hairpin structure located in the 5’ noncoding region of ferritin
mRNA ,which is responsible for iron regulation of ferritin mRNA translation (Dix, Lin et al.
1992), and named it as iron responsive elements (IRE). The ferritin IRE has 30 nucleotides
containing a 10 base pair stem with bulges and CAGUG terminal nucleotides. The unpaired C8
bulge interrupts the stem and divides the helix into upper stem and lower stem. In the CAGUG
terminal nucleotides, C: G pair up and form the –AGU- loop (Walden, Selezneva et al. 2006)
(Fig 5). Soon after identifying the IRE, researchers found a protein binding to the IRE structure,
the iron regulatory protein (IRP) (Muckenthaler, Gray et al. 1998). IRP binding to the IRE in
ferritin mRNA inhibits ferritin protein synthesis. IRP/IRE binding affinity changes with cellular
iron level fluctuations, which leads to ferritin protein synthesis responding to iron levels.

IRP

binds to ferritin IRE with high affinity at lower iron level and ferritin protein synthesis is
inhibited which answers cellular needs of less iron storage protein. Whereas IRP binds to ferritin
IRE with low affinity at high iron level and ferritin protein synthesis starts which is required by
iron concentration elevation. The coordination between IRP/IRE binding affinity change and
ferritin protein synthesis stabilizes cellular iron.
By using nuclease protection analysis, researchers (Beard, Burton et al. 1996) found IRP binding
spans the entire 30 nucleotide ferritin IRE structure. The ferritin IRE-RNA terminal loop and
lower stem directly contact with the IRP protein. The A15, G16, U17 and C8 are the key
nucleotides for IRP binding to ferritin IRE (Goss and Theil 2011). NMR revealed that the bound
ferritin IRE has significant conformational changes compared to free ferritin IRE. In free ferritin
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IRE, A15 stacks on top of C14:G18 pair whereas in the protein-RNA complex A15 and U16
stack together and stick out from the rest of the IRE structure. Unlike the distorted C8 in
unbound ferritin IRE, C8 is also extends away from the stem (Fig 5).
Soon after identifying IRE in ferritin mRNA, IRE structures were also found in other mRNA
encoding proteins for cellular iron metabolism such as ferroportin, succinate dehydrogenease,
and mitochondrial aconitase(Anderson, Shen et al. 2012). Bedsides the 5’ noncoding regions,
IREs are also found in some mRNA’s 3’noncoding region such as transferrin receptor protein 1
and divalent metal transporter 1(Erlitzki, Long et al. 2002). In contrast to 5’ noncoding region
IRE mRNA inhibition of translation by IRP binding to IRE, IRP binding to the 3’ noncoding
region IRE has positive effects on mRNA translation. By binding with 3’ noncoding IRE, IRP
can inhibit mRNA degradation from the exosome, which increases the life time of the mRNA
and protein synthesis (Erlitzki, Long et al. 2002). Two opposite effects on mRNA translation
caused by IRP binding with IRE have same results in cellular iron regulation. The 3’ noncoding
region IREs are found in iron acquisition proteins, and the 5’ noncoding region IREs are found in
iron storage or utilization proteins.

At low iron concentration, cells need to transport

extracellular iron into the cell which requires more iron acquisition proteins (Active translation
by IRP/IRE binding). At the same time, there is no need to synthesize iron storage or utilization
proteins which have 5’ noncoding region IREs (Repress translation by IRP/IRE binding). At
high iron concentration, the requirement is reversed. What cells need now is iron storage or
utilization proteins (translation activation) not iron acquisition proteins (translation repression)
(Fig 6) (Anderson, Shen et al. 2012). By coordination of IREs, cellular iron concentration is
stable at a constant level.
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Genetically IRE is not a conservative element; IREs have 36% to 85% sequence difference even
in a single organism. However all IREs have conserved structures: 9 to 10 base pair double stand
RNA helix, terminal –CAGUGU/C- nucleotides and an unpaired C8 residue in the helix (Fig 7)
(Piccinelli and Samuelsson 2007).
Recently IRE structures are also been found in the amyloid precursor protein mRNA (Beard,
Burton et al. 1996) and alpha synuclein mRNA (Proudhon, Wei et al. 1996), which implies iron
plays a role in neurodegenerative diseases.
Despite highly diversified IRE sequence, IRP can bind to all IREs. There are two types of IRP in
the cell. IRP1 belongs to the cellular aconitase family which catalyzes the isomeriztion of βhydroxy-acid metabolites. Active aconitases require an Fe-S cluster as a coenzyme. IRP1 is the
apoenzyme of cellular aconitase which only binds to IRE without the Fe-S cluster. IRP1 is
composed of 4 domains. Domain 1 and domain 2 are stable and form the core of IRP1 which is
responsible for aconitase activity. Conformation changes occur in domain 3 and domain 4 when
IRP binds to IRE. The domain 3 rotates 52º and translates ~13 Å and domain 4 rotates 32º and
translates ~14 Å (Fig 5) (Walden, Selezneva et al. 2006). IRP2 has 60% sequence identity to
IRP1, which doesn’t bind Fe-S and does not have any enzyme activity. The unbound IRP2 is
readily degraded.
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Figure 5 Structure of rabbit IRP1 in complex with ferritin H IRE-RNA.
(A) Stereo diagram of IRP1:IRE-RNA complex showing IRP binding with IRE (Ma, Haldar et al.
2012). (B)The IRE-RNA diagram showing the upper stem, lower stem, terminal loop and bulge
C8. C8 and A15 labeling in red. (C) Free IRP conformation (Left) and conformation in complex
with IRE-RNA (Right), 4 domain labeled in different color (Walden, Selezneva et al. 2006)and
(D) Twisted IRE-RNA structure after binding with IRP (Walden, Selezneva et al. 2006)
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Figure 6 IRPs regulate translation and stability of IRE-containing mRNAs (Anderson, Shen et al.
2012).
IRPs bind to IREs located in either the 5’ or 3’ noncoding region of IRE-mRNAs. At low iron
level, IRPs bind to both 5’ IRE and to 3’ IRE with high affinity. 5’ IRE-mRNA translation is
repressed to inhibit iron storage and utilization protein synthesis such as ferritin. And 3’ IREmRNA translation is activated to synthesize iron transporter protein such as TfR1. At high iron
level, IRPs do not bind any IREs. 5’ IRE-mRNA translates into protein such as ferritin to lower
iron level. The 3’ IRE-mRNA is degraded to inhibit iron uptake.
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Figure 7 IREs in different mRNAs (Piccinelli and Samuelsson 2007)
The Listed IREs include Transferrin receptors (Tfr), mitochondrial aconitase (mACO), erythroid
aminolevulinic synthase (eALAS), ferroportin, divalent metal ion transporter (DMT1) , succinate
dehydrogenase (SD), myotonic dystrophy kinase-related Cdc42-binding kinase α (MRCKα), and
cell division cycle 14a (Cdc14a).
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Eukaryotic Translation Initiation
The 5’ noncoding region IRE is a well-known negative control element in mRNA translation.
However, how mRNA translation gets inhibited is still not clear. Cellular mRNA translation has
3 steps: initiation, elongation and termination. Translation initiation is the most complicated and
tightest controlled process compared to elongation and termination (Dever 1999; Kozak 2002;
Schutz, Bumann et al. 2008). The eukaryotic initiation starts with 43S pre-initiation complex
binding to mRNA and finishes with positioning 80S ribosome at the AUG codon. There are at
least 12 eukaryotic initiation factors (eIF) (Gebauer and Hentze 2004) involved in this process.
Eukaryotic initiation can be divided into 3 main steps: mRNA preparation, 43S complex binding
to mRNA, and 80S ribosome formation.
Eukaryotic protein synthesis occurs on a circular mRNA, which needs eIF assistance. The
eukaryotic initiation factor 4F (eIF4F) binds to the 5’cap of mRNA and poly A binding protein
(PABP) binds to the 3’ poly A tail of mRNA. PABP also binds to eIF4F, which enables both
5’end and 3’end of mRNA to bind to eIF4F and circularize mRNA. eIF4F is a protein complex,
which is composed of three eIFs in mammalian cells: eIF4A, an ATP dependent RNA helicase ,
unwinds secondary structure in 5’ noncoding region; eIF4E, the cap binding protein, binds to 5’
cap of mRNA ; and eIF4G, a scaffold protein, has binding domains for other factors such as
PABP. In translation initiation, the 40S subunit of the ribosome binds Met-tRNAiMet, eIF2,
eIF2B, eIF3, eIF1 and eIF1A to form 43S complex. By eIF3 binding to eIF4G, the 43S complex
can access the mRNA. When a 43S complex binds to mRNA, it starts to scan to the first AUG
codon (Preiss and M 2003). After 43S complex reaches the first AUG codon, the initiation
factors are released from the 43S complex and 60S ribosome subunit joins to assemble 80S
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ribosome. The formation of the 80S ribosome indicates finish of translation initiation and start of
translation elongation (Fig 8) (Gebauer and Hentze 2004).
mRNA translation regulation happens on two levels: global control and mRNA specific control.
Global control affects all mRNA translation which usually happens with the initiation factor
modification such as HSV-1 repressing cellular mRNA translation by phosphorylation of eIF4E
(Walsh and Mohr 2004). In specific control, mRNA expression is regulated by RNA specific
hybridizing to noncoding region of mRNA or some protein binding to noncoding region of
mRNA such as IRP binding to IRE. (Gebauer and Hentze 2004)
Research shows that IRP1 binding to IRE prevent 43S complex accessing the mRNA (Paraskeva,
Gray et al. 1999; Gebauer and Hentze 2004), which implies that IRP/IRE interacts with the RNA
preparation step to inhibit translation initiation. Among all eukaryotic initiation factors, eIF4F
firstly binds to 5’ cap of mRNA. Researchers also proved that IRP/IRE interacts with eIF4F to
prevent ribosome accessing the mRNA (Muckenthaler, Gray et al. 1998). However how does
IRP/IRE interact with eIF4F was not clear.
In this thesis, the relationship among eIF4F, IRP and IRE is clarified. By using the fluorescence
techniques, the eIF4F was proved to bind with IRE, and the binding affinity of eIF4F and IRE
was quantitatively measured. The experiments proved that eIF4F competitively binds to IRE
with IRP, which indicates that IRP/IRE blocks mRNA translation by inhibiting eIF4F accessing
IRE. In order to understand the regulation of cellular iron metabolism, the iron’s effects on
eIF4F/IRE binding and IRE conformation were also tested. The results showed that iron
concentration changes have opposite effects on eIF4F/IRE binding, compared with IRP/IRE
binding, and iron induces IRE’ conformation change. Combing all results, a novel mechanism of
mRNA translation regulated through IRP/IRE was revealed.
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Figure 8 Cap-dependent translation intiation. (Gebauer and Hentze 2004)
Translation initiation with 3 steps; mRNA preparation, 43S complex binding to mRNA, 80S
ribosome formation. All initiation factors are listed in the cartoon.
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Method
Fluorescence Techniques
In order to study the relationship between eIF4F with IRP/IRE, techniques to measure
biomolecular interactions were used in this study. Bimolecular interaction analysis includes
filter-binding assay, electrophoretic mobility shift assay (EMSA), isothermal titration
calorimetry (ITC) and fluorescence measurement. In this research, powerful fluorescence
techniques are chosen to study the biomolecular interactions. The fluorescence can measure
affinity in solution giving true equilibrium binding constants compared with other methods such
as filter-binding assay and EMSA. The ITC also can be measured in solution, but it needs more
material and higher concentration compared with fluorescence (Anderson, Larkin et al. 2008).
In fluorescence measurements, emission intensity and anisotropy are two main methods to detect
environmental changes and molecular motion. Emission intensity can be changed when
fluorescence producing substance such as protein binds to the other substance such as RNA. By
measuring the fluorescence intensity change, the binding affinity between two molecules can be
quantified. Fluorescence anisotropy detects the rotation of a fluorophore by exciting the
fluorophore with a polarized excitation light. If the excitation is vertical (Ivv), the anisotropy is
measured by the vertical (Ivv) and horizontal (Ivh) emission beam (Fig 9). The anisotropy is
calculated by the following equation
r= (Ivv- Ivh)/ (Ivv+2Ivh)
If a fluorophore rotates slower in solution than the fluorescent life time, the anisotropy will be
large because I‖ value is larger than I⊥ value. If a fluorophore rotates rapidly relatively to its life
time; the anisotropy will be close to zero because I‖ value is equal to I⊥ value. The binding of
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protein to a fluorophore labeled RNA, the increase of mass is sufficient to decrease the rotation
rate of the fluorophore and change the anisotropy (Anderson, Larkin et al. 2008).
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Figure 9 Geometry of fluorescence anisotropy experiment (Visser. Antonie J and Rolinski. Olaf).
The polarized light excites the fluorophores in the cuvette. The emission intensity of vertically
(Ivv) and horizontally (Ivh) polarized fluorescence is measured
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Protein preparation
The proteins used in this research is listed in Table 1
The eIF4F protein was kindly provided by Professor William C. Merrick and purified from
rabbit reticulocyte lysate (RRL) as described (Grifo, Tahara et al. 1983).
The IRP1 was kindly provided by Professor Elisabeth C. Theil and purified from yeast as
described in reference (Erlitzki, Long et al. 2002; Khan, Walden et al. 2009).
All eIF4G proteins were expressed in BL21 cells and induced by 0.8 mM IPTG at 15 °C. The
induced cells were collected by centrifugation at 4500 rpm. The harvested cells were suspended
in PBS buffer and sonicated. The sonicated cell lysate was centrifuged at 13500 rpm for 30 mins.
After centrifugation, the supernatant was filtered by 0.45 µM filter and loaded to GS Trap FF
(GE healthcare life science). The column was washed by PBS buffer and eluted by elution buffer
(50 mM Tris·HCl pH 8.0 and 20 mM reduced Glutathione). The eluted protein was transferred to
10 kDa cutoff dialysis bag and dialyzed in two Liter dialysis buffer (50 mM potassium acetate
KOAc, 20 mM Tris·HCl pH 8.0 0.1 mM EDTA, 1 mM DTT and 10% glycerol). After overnight
dialysis, the protein was concentrated by dialysis against PEG 8000 for 20 min. The concentrated
protein was stored at -80 °C for future use. The purity of the protein was tested by 12% SDSPAGE and the concentration of protein was determined by the Bradford method with bovine
serum albumin as the standard using a Bio-Rad protein assay reagent.
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Protein

Vector

Host

Purification

eIF4G M domain (626-1045)

pGEX-4T-eIF4G(M)

E.coli BL21

GS Trap FF (GE
healthcare

life

Science)
eIF4G

C

terminal

domain pGEX-4T-eIF4G(C)

E.coli BL21

(1045-1560)

GS Trap FF (GE
healthcare
Science)

eIF4F (Mammalian)

Kindly provided by Professor Merrick

IRP1

Kindly provided by Professor Theil

Table 1Proteins used in iron regulating eukaryotic mRNA translation initiation.

life
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RNA preparation
The oligosnucleotides are listed in Table 2
Fluorescein-labeled 30 nt ferritin IRE-RNA, Fluorescein-labeled 25 nt mitochondrial aconitase
IRE-RNA, 2-aminopurine substituted 30 nt IRE-RNA, and 73 nt ferritin mRNA noncoding
region DNA oligos (template for in vitro RNA transcription) were purchased from Genelink or
IDT (Table 2). After dissolving in titration buffer (40 mM HEPES, pH 7.2, 100 mM KCl, 5%
glycerol), all RNAs were melted at 85 °C for 15 min and reannealed by slowly cooling to 25 °C
before use.

The concentrations of RNA were determined spectrophotometrically from the

measured absorbance at 260 nm with 1.0 A260/mL = 40 μg/mL RNA.
RNA Transcription and Capping
The 73nt ferritin mRNA noncoding region was transcribed by T7 RNA polymerase at 37 °C for
4 hours. The transcription system was listed in the following Table 2. The purchased DNA oligos
with T7 promoter sequence (italicized in the table 1) were dissolved in titration buffer. The
positive strand DNA and negative strand DNA were mixed by 1:1 ratio, melted at 85 °C for
5 min and annealed at room temperature to form the final transcription template. After
transcription, the RNA was purified by RNA purification kit (Zymo Research) and the
concentration was quantified by absorbance at 260 nm with 1.0 A260/mL = 40 μg/mL RNA. The
RNA was capped by vaccinia capping enzyme system (listed in Table 4) at 25 °C for 3 hours.
RNA capping efficiency is tested by Malachite Green Phosphate Assay. (Feng, Chen et al. 2011)
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Name

Sequence

Fluorescence labeled Ferritin IRE- FL5’GUUCUUGCUUCAACAGUGUUG

Sources
Genelink

AACGGAAC3’

RNA

Fluorescence labeled mitochondrial FL5’UCAUCUUUGUCAGUGCACAAA
aconitase IRE

AUGG3’

Fluorescence labeled 5S RNA

FL5’UAGUACUUGGAUGGGAGACCG

Genelink

IDT

CCUGGGAAU3’
73 nt ferritin

5’ noncoding region 5’TAATACGACTCACTATAGGGATCTA

DNA Positive strand

IDT

CACCTGACTCTTAGTAGAGTTCTTG
CTTCAACAGTGTTTGAACGGAACCC
TCTCTGAGTCCTTTGCTC3’

73 nt ferritin 5’ noncoding region 5’GAGCAAAGGACTCAGAGAGGGTT
DNA Reverse strand

IDT

CCGTTCAAACACTGTTGAAGCAAG
AACTCTACTAAGAGTCAGGTGTAG
ATCCCTATAGTGAGTCGTATTA3’

2-aminopurine substituted C8 Ferritin 5’GUUCUUG-2APUUCAACAGUGUUGAACGGAAC3’

IRE-RNA
2-aminopurine
Ferritin IRE-RNA

IDT

substituted

A15 5’GUUCUUGCUUCAAC-2APGUGUUGAACGGAAC3’

Table 2 Purchased nucleotides
FL: Fluorescein labeled; Italic bases: T7 promoter

IDT
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Ingredients

Concentration

Ingredients

Concentration

NTPs

5 mM for each

Pyrophosphatase

0.1 unit/ mL

GMP

5 mM

RNase Out

0.2 unit/ mL

Mg2+

20 mM

T7 RNA polymerase

50 units/ mL

PEG 8000

5%

Tris·HCl (pH 8.0)

40 µM

DTT

10 mM

Triton X-100

0.01%

Spermidine

1 mM

DNA template

5 mM

Table 3 Transcription System
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Ingredients

Concentration

Ingredients

Concentration

GTP

2 mM

Vaccinia capping

1 units / mL

enzyme
S-Adenosyl

1 mM

Tris·HCl (pH 8.0)

50 µM

KCl

5 mM

MgCl2

1 mM

DTT

1 mM

methionine (SAMs)

Table 4 RNA m7GTP Capping system
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Eukaryotic initiation factors (eIFs) binding to IRE-RNA.
The equilibrium constants for eIF4F, eIF4G(M) and eIF4G(C) binding to ferritin IRE-RNA were
separately determined by monitoring the fluorescence anisotropy change. Fluorescein labeled
ferritin IRE-RNA (50 nM) was titrated by eIFs in buffer (20 mM HEPEs, pH 7.4, 100 mM KCl)
at 25 °C. The KD values were determined by fitting the plot of changes in anisotropy vs. eIFs
concentration using the equation robs = rmin + {(rmax-rmin)/(2[IRE])}{b-(b2 - 4[IRE][eIF4F])0.5}
where the robs is the observed anisotropy value; rmin the minimal anisotropy value; rmax is final
saturated anisotropy value; [IRE] and [eIF4F] are the total concentrations of IRE-RNA and
eIF4F protein, respectively; b = KD + [IRE] + [eIF4F] as described (Luo and Goss 2001; Khan
and Goss 2005). Data were fit to equations by using KaleidaGraph (Abelbeck Software). For the
metal ions’ effects on eIF4F/IRE binding, various concentrations of metal ions, such as Fe2+
(titration is carried in an inert atmosphere )and Mn2+, were added to titration buffer before
titration. Other procedures and calculation are similar to previous describe.
eIF4G binding to 5’ noncoding region of ferritin mRNA (73nt).
The equilibrium constants for eIF4F binding to 5’ noncoding region of ferritin mRNA (73nt)
were determined by monitoring the intrinsic fluorescence intensity change of eIF4F. eIF4F (50
nM) was titrated by RNA in buffer (20 mM HEPEs, pH 7.4, 100 mM KCl) at 25 °C. The KD
values were determined by fitting the plot of changes in fluorescence intensity vs. RNA
concentration using the equation F= {2F0KD- F∞*b+ F∞*(b2-4 [eIF4F][RNA])1/2 }/{b+ (b2-4
[eIF4F][RNA])1/2 }(Thorp, McKenzie et al. 1996) where F0 : fluorescence intensity before
titration, F∞ : fluorescence intensity when IRE saturated binding with eIF4F, b= K D +[eIF4F] +
[RNA] as described. Data were fit to equations by using KaleidaGraph (Abelbeck Software).
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eIF4F and IRP Competitive Binding for IRE-RNA.
Fluorescein labeled ferritin IRE-RNA (50 nM) was mixed with varying concentrations of eIF4F
protein. The eIF4F and FL-ferritin IRE-RNA mixture was titrated by IRP1 protein as described
above. The data were analyzed using the Lineweaver–Burke plot, 1/r-robs vs 1/[IRP]. Intersection
of the lines at the same point on the Y-axis indicated competitive binding contrasting with the
parallel lines that would be observed for uncompetitive binding. Data were fit by using
KaleidaGraph (Abelbeck Software).
IRE-RNA conformation changes with iron concentration changes
Freshly prepared solutions of FeSO4 in deoxygenated (argon-purged) water were titrated
anaerobically to argon-purged solutions of the reannealed 2AP substituted IRE-RNAs (50 nM),
and the fluorescence change of 2AP was monitored at the same time. The experiments were
performed in an inert atmosphere as described (Khan, Walden et al. 2009).
Kinetics study of eIF4F/IRE-RNA binding
By using OLIS RSM 1000 stopped-flow system (Fig 10), the binding of IRE-RNA and eIF4F
protein was monitored by anisotropy change with 1-ms dead time at 25 °C after rapid mixing
200 nM fluorescein labeled IRE-RNA with 200 nM eIF4F protein. The fluorescein labeled
Ferrtin IRE-RNA was excited at 490 nm and the emission is detected using a 500 nm cut-on
filter. All measurements were performed in titration buffer, 40 mM HEPES, pH 7.2, 100 mM
KCl, 5% glycerol and 2% 2-mercaptoethanol. 1000 pairs of data were collected in one mixing
shot. In order to improve signal-to noise ratio, 5 sets of data were averaged. The averaged set of
data was fitted to heterogeneous 2nd order reaction by using Global analysis software provided
by OLIS.
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Figure 10 OLIS RSM 1000 stopped-flow system
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Results
eIF4F binds to Ferritin IRE-RNA not control 5S RNA
Previous research showed that as a negative control element IRP/IRE complexes stability
responds to cellular iron concentration changes. Previous studies (Dix, Lin et al. 1992) showed
that in the IRP depletion system, ferritin mRNA translation efficiency is lower in the IRE
deletion mutation than the m7GTP cap deletion mutation which has whole ferritin mRNA
without m7GTP cap. Those data showed that IRE may be a positive element in translation. The
eIF4F/IRE binding assay showed that eIF4F binds to IRE-RNA (KD =39.8±5.6 nM) but not 5S
RNA (KD >1 mM) (Fig 11). eIF4F specifically binding to IRE-RNA indicates that IRE can help
the ribosome locate on the mRNA, which is consistent with IRE functioning as a positive
control element in translation.
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Figure 11 eIF4F binding to ferritin IRE -RNA
Protein binding to RNA monitored by changes in 5’ fluorescein(Ohgami, Campagna et al.)
labeled RNA (50 nM) fluorescence anisotropy (excitation- 490 nm, emission- 520 nm) in
titration buffer. eIF4F tightly binds to ferritin IRE-RNA (KD =39.8±5.6 nM) but not 5S RNA
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Metal ion’s effects on eIF4F/IRE-RNA complexes
After increasing the iron concentration anaerobically to 50 µM in titration buffer, eIF4F/IRE
RNA binding affinity increases (KD =9.5±2.4 nM) (Fig 12, 15), which is similar to binding
affinity between eIF4F and encephalomyocarditis virus (EMCV) RNA and tighter than binding
affinity between eIF4F and β-globing mRNA (Lomakin, Hellen et al. 2000). Other metal ion’s
effects on eIF4F/IRE binding were tested. Mn2+, whose size is similar to Fe2+, had the same
effect on eIF4F/IRE binding as Fe2+ (Fig 14, 15); whereas another divalent ion, Mg2+, also
increased the eIF4F/IRE binding but the strength was not as much as Fe2+ or Mn2+ (Fig 13,15)
(Table 5). Data show that 1000 µM Mg2+ has similar effects on eIF4F/IRE binding as 5 µM Fe2+
or Mn2+. By conjoining the data (Ma, Haldar et al. 2012), the metal has opposite effects on
IRP/IRE binding in contrast to eIF4F/IRE binding (Fig 17).
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Figure 12 eIF4F/ IRE –RNA binding affinity increases with iron concentration elevation.
50 µM FeSO4 added to anaerobic titration buffer with IRE-RNA (50 nM for 0 50 µM FeSO4 and
20 nM for 50 µM FeSO4) before titration experiment. Iron (50 µM FeSO4) increases IF4F/IRE
binding affinity (KD=9.5±2.4 nM).
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Figure 13 eIF4F/ IRE –RNA binding affinity increases with 1mM MgCl2.
eIF4F/ IRE-RNA binding affinity increases with 1mM MgCl2 (KD=29.9±6.9 nM).
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Figure 14 Mn2+ and Fe2+ have similar effects on eIF4F/ IRE –RNA binding.
eIF4F is titrated to 25 nM 5’ fluorescein(Ohgami, Campagna et al.) labeled IRE-RNA. 50 µM
Mn2+ (Circle ○) increases eIF4F/IRE-RNA binding affinity , which is similar to 50 µM Fe2+
(Diamond ◊)
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Figure 15 Metal ion affects eIF4F-IRE binding
Fe2+/Mn2+ have large effect on eIF4F-IRE binding compared to Mg2+. (Black bar: No metal ion;
Blue bar: Mg2+; Green bar: Mn2+; Red bar: Fe2+) The concentration of each metal ion is
indicated on the X axis.
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Mn2+

Fe2+

Mg2+

39.8±5.6 nM

0 µM
5 µM

25.1±3.5 nM

31.2±3.6 nM

*

25 µM

16.8±5.6 nM

17.7±4.9 nM

*

50 µM

9.4±2.9 nM

9.5±2.4 nM

*

1000 µM

*

*

29.9±6.9 nM

Table 5 Metal ion affects eIF4F-IRE binding
*The concentration is not tested.
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IRP, eIF4F competitively binds to ferritin IRE-RNA
eIF4F binding to IRE raises a question: What is the relationship among eIF4F, IRP and IRERNA.
The competitive binding experiments were conducted. IRP was added to eIF4F/IRE complexes
(various eIF4F concentrations). After using Lineweaver-Burk plot to analyze the competitive
experiments, the results showed that eIF4F and IRP competitively bind to IRE-RNA (Fig 16).
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Figure 16 Competitive binding of eIF4F and IRP1 to Ferritin IRE-RNA
50 nM ferritin IRE-RNA with various concentration of eIF4F (Triangle, 0 nM; circle, 10 nM;
square, 20 nM) was titrated with IRP1 protein. Convergence of lines (1/[IRP] vs 1/∆r ) on the Y
axis (circle) indicates competitive binding
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Iron induces ferritin IRE conformation change
Since IRP and eIF4F competitively bind to ferritin IRE-RNA, iron has opposite effects on those
two proteins’ binding with ferritin IRE-RNA (Fig 17). Iron decreases IRP/IRE binding affinity,
but iron increases binding affinity of eIF4F/IRE, which answers the cellular requirement for
more iron storage protein to stabilize the cellular iron level. However, previous IRP/IRE mRNA
regulatory mechanism only focused on iron induced protein conformational change of IRP. Now
results show that iron also has effects on eIF4F/IRE binding, which suggests another regulatory
mechanism.

Iron might induce IRE-RNA’s conformational change. To test IRE-RNA

conformational change with different iron concentrations, 2 aminopurine (2AP) was used to
substitute key bases (C8 and A15) in ferritin IRE-RNA. 2 aminopurine, a fluorescent base analog
of guanine and adenine, has been widely used in nucleic acid conformation research for its
fluorescence intensity changes with environmental change (Barnes, Theil et al. 1998). When
2AP stacks with other bases, 2AP’s fluorescence is quenched and fluorescence intensity
decreases. In my research, two key bases of IRE-RNA, C8 and A15, in IRP/IRE binding were
replaced by 2 AP individually. As stated before, C8 is oriented away from the stem and A15
stacks with G16 required in IRP/IRE binding state. Firstly, iron has only minor effects on
fluorescence intensity of 2AP alone decreasing the intensity by less than 10% (Fig 18). It was
found find that iron decreased fluorescence intensity by around 75% of 2AP substituted C8
ferritin IRE-RNA substitute (Fig 19, 21). In contrast to C8, the fluorescence intensity of A15
substituted IRE-RNA increased by around 100% (Fig 20, 21).

C8 substitute IRE-RNA

fluorescence decrease most likely is caused by C8 interacts with the stem of IRE upon addition
of iron. A15 substitute IRE-RNA intensity increase suggests A15 is less stacked with G16 upon
increased iron concentration. Those two changes are predicted to have negative effects on
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IRP/IRE binding. The key for IRE binding to IRP is the C8 oriented away from stem (Fig 5D).
The C8 is inserted into a pocket in the IRP1 domain 4 and sandwiched between 2 arginine
residues (Walden, Selezneva et al. 2006). The A15 stacking G16 is also required for IRP/IRE
binding (Fig 5D). The pair of A15 and G16 extends into a cavity of the IRP and interacts with
residues inside of cavity (Walden, Selezneva et al. 2006). With the increased iron concentration,
the IRE conformation changes lead to C8 interacting with stem and A15, G16 pair separating
which explains IRP/IRE binding affinity decreasing.
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Figure 17 Opposite effects of anaerobic Fe2+ on ferritin IRE-RNA binding of IRP and eIF4F.
eIF4F-IRE with Fe2+ █ (from panel A); IRP1-IRE-RNA with Fe2+ █ Data of IRP1 binding to
ferritin IRE-RNA is from (Khan, Walden et al. 2009)
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Figure 18 Iron has minor effects on the fluorescence intensity of 2 amino purine
The fluorescence spectra of 50 nM 2AP in anaerobic titration buffer with different FeSO4
concentrations (Excitation: 330 nm).
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Figure 19 Iron decreases the fluorescence intensity of 2AP substituted C8 ferritin IRE-RNA.
The fluorescence spectra of 50 nM of 2AP substituted C8 ferritin IRE-RNA in anaerobic titration
buffer with different FeSO4 concentrations (Excitation: 330 nm).
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Figure 20 Iron increases the fluorescence intensity of 2 AP substituted A15 ferritin IRE-RNA.
The fluorescence spectra of 50 nM 2 AP substituted A15 ferritin IRE-RNA in anaerobic titration
buffer with different FeSO4 concentrations ( Excitation: 330 nm).
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Figure 21 Iron’s effect on the IRE-RNA substituted with 2AP at A15 and the IRE-RNA
substituted with 2AP at C8.
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eIF4F also binds to mitochondrial aconitase IRE-RNA.
In order to determine eIF4F binding to other IRE-RNA, binding affinity of eIF4F with
mitochondrial aconitase IRE-RNA was also tested (Fig 22). The anisotropy experiment showed
that eIF4F had similar binding affinity to ferritin IRE-RNA as compared to mitochondrial
aconitase IRE-RNA (KD=32.9±5.4 nM) (Fig 23).
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Figure 22 eIF4F binds to mitochondrial aconitase IRE –RNA
Protein binding to RNA monitored by changes in 5’ fluorescein(Ohgami, Campagna et al.)
labeled mitochondrial aconitase IRE-RNA (50 nM) fluorescence anisotropy (excitation- 490 nm,
emission- 520 nm) in titration buffer. eIF4F binds to mitochondrial aconitase IRE-RNA with
high affinity (KD=32.9±5.4 nM).
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Figure 23 eIF4F has similar binding affinity to mitochondrial aconitase IRE-RNA and ferritin
IRE-RNA.
eIF4F was added to 50 nM 5’ fluorescein(Ohgami, Campagna et al.) labeled IRE-RNA. eIF4F
binding to mitochondrial aconitase IRE-RNA (Circle ) (KD=32.9±5.4 nM) was similar to eIF4F
binding to ferritin IRE-RNA (Diamond) (KD=39.8±5.6 nM).
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eIF4F/IRE-RNA kinetic study
In order to further understand the relationship among eIF4F, IRP1 and IRE-RNA, stopped-flow
was used to study the kinetic reaction of eIF4F/IRE-RNA binding. The eIF4F/IRE-RNA binding
was a heterogeneous second order reaction (Fig 24) and the forward reaction rate constant,
kon ,was 2.07 ± 0.1 µM-1s-1 (Fig 24).
Equation,

kon [IRE-RNAfinal+ Proteinfinal]+koff (Wickiser, Cheah et al. 2005), was used to

calculate the life time of eIF4F/IRE-RNA complexes (Table 6). The life time of eIF4F/IRE-RNA
complex was 3.65 s. Using the data from lab member Dr. Mateen Khan, the life time of
IRP/IRE-RNA complexes was 0.031 s which is much shorter than eIF4F/IRE-RNA complex
(Table 5). The shorter lifetime of IRP/IRE-RNA indicates that IRP/IRE-RNA complex as a
regulator system responds promptly to cellular conditional changes. As a positive control
element eIF4F/IRE-RNA complex may stabilize circularized mRNA in the translational process,
which has a longer lifetime.

.
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Figure 24 Kinetic study of eIF4F binding to ferritin IRE-RNA
Fluorescence labeled Ferritin IRE-RNA (100 nM) was mixed with eIF4F (100 nM) by stopped
flow. The anisotropy change was recoded with time (1 ms dead time). Data were fitted to 2nd
order heterogeneous reaction: forward reaction rate = kon * [eIF4F] * [IRE]. kon =2.07 ± 0.1 µM1 -1

s
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IRE-RNA + 4F

IRE-RNA + IRP1 *

kon (µM-1s-1)

2.07 ± 0.1

397 ± 7.3

koff (s-1)

0.08*

6.2 ± 0.3

KD (nM)

39.8 ± 0.1

15.6

τ (s)

3.65

0.031

Table 6 Life time of eIF4F/ ferritin IRE-RNA complexes and IRP1/ ferritin IRE-RNA complexes
*

*

IRE-RNA+ IRP1 data are from lab member Dr. Mateen Khan’s research.

The result of koff (IRE-RNA+4F ) was calculated by using the equation: koff = kon / KD
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m7GTP cap effects on eIF4F or IRP1 binding to 5’ noncoding region of ferritin mRNA.
Compared to other mRNA translation control elements such as poly A tail, the m7GTP cap is the
closest mRNA translation control element to ferritin IRE (within 50 nucleotides). In order to
understand the relationship between m7GTP cap with IRE-RNA, the first 73 nt of ferritin mRNA
(including IRE) were made by in vitro transcription (Fig 25). The study was carried to learn the
difference between capped and non-capped the first 73 nt 5’ noncoding region of ferritin mRNA
binding with eIF4F or IRP1.
eIF4F binding to capped or non-capped 73 nt of ferritin mRNA was monitored by fluorescence
quenching. The data are plotted and fitted to the equation F= {2F0KD- F∞*b+ F∞*(b2-4
[eIF4F][RNA])1/2 }/{b+ (b2-4 [eIF4F][RNA])1/2 }(Thorp, McKenzie et al. 1996) where F0 :
fluorescence intensity before titration, F∞ : fluorescence intensity when IRE saturated binding
with eIF4F, b= KD +[eIF4F] + [RNA] (Fig 26) (Table 7). IRP1 binding to capped or non-capped
the first 73 nt 5’ noncoding region of ferritin mRNA is shown (Fig 27) (Table 7).
Both IRP 1 and eIF4F have no significant difference in binding between capped and uncapped
the first 73 nt 5’ noncoding region of ferritin mRNA.
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Figure 25 The secondary structure of the first 73 nt of ferritin mRNA (Harrell, McKenzie et al.
1991)
The first 73nt of ferritin mRNA is predicted to have a large hairpin structure with the IRE inside.
The IRE region is indicated in the solid line.
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Figure 26 eIF4F binding with capped or non-capped first 73nt of ferritin mRNA
The intrinsic fluorescence intensity change of eIF4F protein (50 nM) was monitored with
increasing RNA concentration. The uncapped first 73 nt of ferritin mRNA (Square ■) binds to
eIF4F with high binding affinity (KD: around 10 nM*). The capped first 73 nt of ferritin mRNA
(Circle ●) binds to eIF4F with high binding affinity (KD:13.5±2.4 10 nM*). *Both the capped and
uncapped 73nt ferritin mRNA shows high binding affinity to eIF4F. However with 50 nM eIF4F
protein, KD could not be accurately determined. However with 50 nM IRP protein, KD could not
be accurately determined below 10 nM. Decreasing protein concentration in the titration could
not give enough signals to measure binding affinity.
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Figure 27 IRP1 binding with capped or non-capped first 73nt of ferritin mRNA
The intrinsic fluorescence intensity change of IRP1 protein (50 nM) was monitored with
increasing RNA concentration. The uncapped first 73 nt of ferritin mRNA (Square ■) bound to
IRP with high binding affinity (KD: 11.7±2.7 nM). The capped first 73 nt of ferritin mRNA
(Circle ●) bound to IRP1 with high binding affinity (KD: around 10 nM). *Both the capped and
uncapped 73nt ferritin mRNA showed high binding affinity to IRP. However with 50 nM IRP
protein, KD could not be accurately determined below 10 nM. Decreasing protein concentration
in the titration could not give enough signals to measure binding affinity.
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m7GTP capped the first 73 Uncapped the first 73 nt of
nt of ferritin mRNA

ferritin mRNA

eIF4F (nM)

13.5±2.4

Around 10

IRP1 (nM)

Around 10

11.7±2.7

Table 7 Disassociation Constants, KD, of eIF4F or IRP1 binding with first 73 nt of ferritin
mRNA (capped or uncapped ).
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eIF4G middle domain binds to ferritin IRE-RNA and mitochondrial aconitase IRE-RNA.
Among three subunits of eIF4F, the subunit is responsible for IRE-RNA binding is not known.
With recent evidence of RNA binding motifs in eIF4G (Takagi, Shi et al. 1998), the candidate
for IRE-RNA binding was eIF4G. The middle domain of eIF4G has been proven to have RNA
binding motifs (Epsztejn, Kakhlon et al. 1997). In order to test whether eIF4G has binding
affinity to IRE-RNA, the eIF4G middle domain (626-1045) and eIF4G C terminal domain (10451560) were expressed and purified from E.coli. The eIF4G middle domain was shown to bind
with ferritin IRE-RNA (KD =122.1±21.8 nM) (Fig 28) and mitochondrial aconitase IRE (KD
=81.2±11.4 nM) (Fig30). The eIF4G middle domain also competitively binds to ferritin IRERNA with IRP1 (Fig 29). At the same time, eIF4G C terminal domain was shown no binding
with ferritin IRE-RNA (Fig 31).
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Figure 28 eIF4G middle domain (626-1045) binding to ferritin IRE –RNA
Protein binding to RNA monitored by changes in 5’ fluorescein(Ohgami, Campagna et al.)
labeled ferritin IRE-RNA (50 nM) fluorescence anisotropy (excitation- 490 nm, emission- 520
nm)

in titration buffer. eIF4G middle domain tightly binds to ferritin IRE-RNA

=122.1±21.8 nM).

(KD
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Figure 29 Competitive binding of eIF4G middle domain (626-1045) and IRP1 to Ferritin IRERNA
50 nM ferritin IRE-RNA with various concentration of IRP1 (shows in inset) was added with
eIF4G middle domain protein. Convergence of lines (1/[eIF4GM] vs 1/∆r ) on the Y axis (circle)
indicating competitive binding
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Figure 30 eIF4G middle domain (626-1045) binding to mitochondrial aconitase IRE –RNA
Protein binding to RNA monitored by changes in 5’ fluorescein(Ohgami, Campagna et al.)
labeled mitochondrial aconitase IRE-RNA (50 nM) fluorescence anisotropy (excitation- 490 nm,
emission- 520 nm) in titration buffer. eIF4G middle domain tightly binds to mitochondrial
aconitase IRE-RNA (KD =81.2±11.4 nM).
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○ eIF4G C terminal
◊ eIF4G Middle domain

Figure 31 eIF4G C terminal (1045-1560) does not bind to ferritin IRE –RNA
Protein binding to RNA monitored by changes in 5’ fluorescein(Ohgami, Campagna et al.)
labeled ferritin IRE-RNA (50 nM) fluorescence anisotropy (excitation- 490 nm, emission- 520
nm) in titration buffer. eIF4G C terminal does not binds to ferritin IRE-RNA (Circle ○),
whereas eIF4G middle domain binds to ferritin IRE-RNA (KD =122.1±21.8 nM) (Diamond ◊).

63

Summary of protein/IRE-RNA complexes binding affinity

Ft IRE

Mt IRE

Capped 73 nt

Uncapped 73 nt

eIF4F (nM)

39.8±5.6

32.9±5.4

13.5±2.4

Less than 10

IRP 1 (nM)

*14.2±0.3

*41.3±0.7

Less than 10

11.7±2.7

eIF4G M (nM)

122.1±21.8

81.2±11.4

Not Available

Not Available

eIF4G C (nM)

No binding

Not Available

Not Available

Not Available

Table 8 Protein/IRE-RNA complexes binding affinity
eIF4G M: eIF4G middle domain (626-1045) expressed in E.coli
eIF4G C: eIF4G c terminal (1045-1560) expressed in E.coli
Ft IRE: ferritin IRE-RNA
Mt IRE: mitochondrial aconitase IRE-RNA
Capped 73 nt: The first 73 nt of ferritin mRNA capped with m7GTP
Uncapped 73 nt: The first 73 nt of ferritin mRNA
*Data from the reference (Khan, Walden et al. 2009)
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Discussion
The small RNA structure in the 5’ noncoding region of mRNA affecting eukaryotic protein
synthesis is illustrated by the ability of IRE-RNA to bind, competitively, to two regulatory
proteins. Besides binding to IRP, a protein synthesis inhibitor, IRE-RNA also binds eIF4F which
is the protein synthesis enhancer and known as a rate-limiting step in protein synthesis. As a
well-known mRNA translation control mechanism, phosphorylation of eIF proteins themselves
or eIF binding proteins, alters binding affinity of the proteins with mRNA under a variety of
cellular conditions (Jackson, Hellen et al. 2010). A novel mechanism of translation initiation
mechanism regulated by iron is shown in this research. Iron interacting with the small RNA
structure located in the noncoding region of mRNA such as IRE-RNA stabilizes eIF/RNA
binding.

Increases in eIF4F/ ferritin IRE-mRNA binding facilitated by Fe2+ occur at

concentrations 100 times lower than with Mg2+ and with stabilities 20-1000 times higher than
for eIF4F binding to - globin mRNA or the m7G cap structure (Lomakin, Hellen et al. 2000)
(Marintchev, Edmonds et al. 2009).
Small, shapely molecules such as Cu1+- phenathroline or Ru2+-tris(bipyridyl) binding to
selective sites on IRE-RNA (Wang, Sczekan et al. 1990; Thorp, McKenzie et al. 1996) has been
known for some time. The possibility of Fe2+ binding to IRE-RNA in ferritin mRNA was
suggested by the results of IRE-RNA cleavage with Fe2+ and hydrogen peroxide (Lv, Yan et al.
2012). The unusual pattern of hypersensitive cleavage sites was initially explained as solvent
access prevented by RNA folding, a supposition that was not supported by NMR structures
obtained later (Gdaniec, Sierzputowska-Gracz et al. 1998; Zhao, Jian et al. 2012). Alternatively,
the hypersensitive sites could indicate Fe2+/RNA binding sites. Experiments with 2AP
substituted IRE-RNA showed that Fe2+ altered the conformation of both the terminal IRE loop
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and the C8 bulge. A15 and C8 are part of the two IRE-RNA/IRP1 contact sites and have multiple
contacts (Ke, Wu et al. 1998; Hall, Williams et al. 2004; Walden, Selezneva et al. 2006). There
are some shortcomings of 2AP experiments. 2AP experiments cannot give detailed information
of conformational changes in all nucleotides,

and it cannot identify the Fe2+ binding sites on

IRE-RNA. Other experimental methods need to be employed in Fe2+ /IRE-RNA interaction
research. In this research, all experiments were conducted in vitro, in the solution. How do
IRP/IRE and eIF4F/IRE complexes respond to physiological iron concentration changes? By
fluorescence quenching analysis and potentiometric methods (Epsztejn, Kakhlon et al. 1997;
Hider and Kong 2011), physiologically free [Fe2+] was measured at ~0.5-1.0 µM in normal
mammalian cells. At intracellular [Fe2+] ~5-10 µM, detectable ferritin protein accumulations can
be immunologically measured. These data show, at 5-10 µM [Fe2+] in solution, a 6:1 decrease
in IRP binding and a 1.5:1 increase in eIF4F binding (Figure 14). Because eIF4F and IRP bind
competitively (Figure 13), the IRE/eIF4F complex can increase 8:1, for similar IRP:eIF4F
concentrations at 5 µM [Fe2+]. The effect could be 80:1, at 50 µM Fe2+.
A model of ferritin IRE-mRNA riboregulator function (Figure 32) was proposed, which
combines Fe2+ regulating IRE-mRNA-IRP inhibition of protein synthesis with Fe2+ regulating
IRE-mRNA-eIF4F enhancement of protein synthesis (Zahringer, Baliga et al. 1976; Theil and
Eisenstein 2000; Wallander, Leibold et al. 2006). The model also includes the inactivation of
IRP for IRE-RNA binding from previous models (Johnson, Dean et al. 2005; Rouault 2006;
Leipuviene and Theil 2007; Salahudeen, Thompson et al. 2009; Vashisht, Zumbrennen et al.
2009). Increasing cellular concentrations of Fe2+ will induce IRE-RNA conformation change,
lower RNA/IRP affinity, and increase eIF4F binding affinity, which leads to ribosome assembly
and mRNA translation.
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Figure 32 Model for IRE-RNA riboregulator action
1) At low iron concentration, ribosome assembly is inhibited by IRP binding to IRE-mRNA.
2) When iron concentration increases, Fe2+ causes an IRE-RNA conformational change
which favors eIF4F/IRE-RNA binding and decreases IRP/IRE-RNA binding.
3) After eIF4F binding to the IRE-mRNA, eIF4F recruits the ribosome and ferritin protein
synthesis (translation and expression) begins.
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The m7GTP cap structure is a strong positive control element in eukaryotic protein synthesis.
The IRE structure is located within 40 nt of m7GTP cap in the 5’ noncoding region (Gebauer
and Hentze 2004). Binding affinity showed the m7GTP cap had no effect on IRP or eIF4F
binding to mRNA. Previous studies showed that IRE structure has a greater effect on ferritin
mRNA translation in the depleting IRP protein translation system than 5’ m7GTP cap. Ferritin
mRNA also translates without 5’end cap but not IRE structure (Dix, Lin et al. 1992). eIF4F
binding with IRE-RNA indicates that IRE can be a positive control element for mRNA
translation. Studies show that IRE is still a positive control element for mRNA translation
without m7GTP cap. At the same time, there is no difference between eIF4F binding to ferritin
IRE-RNA and mitochondrial aconitase IRE-RNA but a significant difference between IRP1
binding to ferritin IRE-RNA and mitochondrial aconitase IRE-RNA (Table 22). All these
evidence implies eIF4F/IRE complex may have other roles in translation initiation besides
interacting IRP/IRE system. Without m7GTP cap, IRE binds to eIF4F and then helps ribosome
access mRNA.

In the eukaryotic cell, internal ribosome entry site (IRES) can recruit the

ribosome to mRNA independent of the m7GTP Cap (Gebauer and Hentze 2004; Komar and
Hatzoglou 2011). Besides similar name, IRE may functions as IRES in the IRE mRNA to initiate
translation.
In order to further understand IRE-RNA regulating mRNA translation, the kinetic of eIF4F/IRE
RNA and IRP/IRE-RNA was studied. These data show that IRP/IRE-RNA complex has a much
shorter lifetime than eIF4F/IRE-RNA complex, but IRP1 binds to and dissociates from IRERNA much faster than eIF4F. As a negative control factor in IRE-RNA translation, the IRP1
needs to bind to IRE-RNA more flexibly than eIF4F in order to respond to cellular iron
concentration changes promptly. On the other hand, eIF4F binding to mRNA is the rate
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determined step in protein translation initiation (Schutz, Bumann et al. 2008). Therefor a longer
life time of eIF4F/IRE-RNA complex is required to stabilize the ribosome on mRNA.
As a three subunits complex, which subunit is responsible for IRE-RNA binding in eIF4F is
answered. The middle domain of eIF4G has been shown to have RNA binding motifs
independent of other two subunits (Sonenberg and Hinnebusch 2009). The IRE/eIF4G binding
results showed that the middle domain of eIF4G binds to IRE-RNA (Table 22). Besides high
affinity between eIF4G middle domain and IRE-RNA, eIF4G middle domain also competitively
binds to IRE with IRP1. The eIF4G C terminal domain was also tested to see whether it binds to
ferritin IRE-RNA. The results showed that eIF4G C terminal domain has no binding affinity to
the ferritin IRE (Figure 31), which verified the eIF4G middle domain binds to ferritin IRE-RNA.
The IRE has been identified as a control element in iron metabolic proteins synthesis since late
last century (Zahringer, Baliga et al. 1976; Wang, Sczekan et al. 1990; Lv, Yan et al. 2012).
Now IRE is also found in mRNAs encoding a cell cycle protein (Sanchez, Galy et al. 2007), α–
hemoglobin chaperone (dos Santos, Dore et al. 2008) and amyloid precursor protein (Beard,
Burton et al. 1996; Proudhon, Wei et al. 1996; Cho, Cahill et al. 2010). Recent extensions of the
IRE-RNA family indicate that IRE-mRNA control of protein synthesis affects a number of
metabolic processes in animal cells and may be more general than previously thought.
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